Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
Kotak Healthcare Fund Direct Growth
NAV: 09 Jun '26
₹15.87
Min. for SIP
₹100
Fund size (AUM)
₹496.00 Cr
Expense ratio
0.87%
Rating
--
Return calculator
Monthly investment
₹5,000
| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 3 months | ₹15,000 | ₹15,934 | +6.23% | |
| 6 months | ₹30,000 | ₹32,887 | +9.62% | |
| 1 year | ₹60,000 | ₹66,559 | +10.93% |
Holdings (35)
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 14.04% |
| JB Chemicals & Pharmaceuticals Ltd | Healthcare | Equity | 6.63% |
| Max Healthcare Institute Ltd | Healthcare | Equity | 6.31% |
| Divi's Laboratories Ltd | Healthcare | Equity | 5.90% |
| Fortis Healthcare Ltd | Healthcare | Equity | 4.84% |
| Ami Organics Ltd | Healthcare | Equity | 4.60% |
| Cipla Ltd | Healthcare | Equity | 4.22% |
| Park Medi World Ltd. | Healthcare | Equity | 3.79% |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | Equity | 3.56% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 3.08% |
| Lupin Ltd | Healthcare | Equity | 3.02% |
| Sai Life Sciences Ltd. | Healthcare | Equity | 3.02% |
| Mankind Pharma Ltd. | Healthcare | Equity | 2.72% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 2.64% |
| Jubilant Pharmova Ltd | Healthcare | Equity | 2.52% |
| Anthem Biosciences Ltd. | Healthcare | Equity | 2.45% |
| Glenmark Pharmaceuticals Ltd | Healthcare | Equity | 2.43% |
| Ajanta Pharma Ltd | Healthcare | Equity | 2.39% |
| Alkem Laboratories Ltd | Healthcare | Equity | 2.07% |
| Rubicon Research Ltd. | Healthcare | Equity | 1.96% |
| CORONA Remedies Ltd. | Healthcare | Equity | 1.91% |
| Marksans Pharma Ltd | Healthcare | Equity | 1.86% |
| Gland Pharma Ltd | Healthcare | Equity | 1.76% |
| Emcure Pharmaceuticals Ltd. | Healthcare | Equity | 1.69% |
| Yatharth Hospital & Trauma Care Services Ltd. | Healthcare | Equity | 1.49% |
| Repo | Unspecified | Repo | 1.41% |
| Orchid Pharma Ltd | Healthcare | Equity | 1.26% |
| Zydus Lifesciences Ltd | Healthcare | Equity | 1.26% |
| Dr. Lal Pathlabs Ltd | Healthcare | Equity | 1.21% |
| Innova Captab Ltd. | Healthcare | Equity | 1.17% |
| Laxmi Dental Ltd. | Healthcare | Equity | 1.14% |
| Rainbow Childrens Medicare Ltd | Healthcare | Equity | 1.09% |
| Metropolis Healthcare Ltd | Healthcare | Equity | 0.76% |
| Medi Assist Healthcare Services Ltd. | Industrials | Equity | 0.23% |
| Net Payables | Unspecified | Net Payables | -0.43% |
See All
Minimum investments
Min. for 1st investment
₹100
Min. for 2nd investment
₹100
Min. for SIP
₹100
Returns and rankings
Annualised returns
Absolute returns
| Name | 3M | 6M | 1Y | All |
|---|---|---|---|---|
| Fund returns | +11.1% | +12.7% | +17.4% | +57.2% |
| Category average (Equity Sectoral) | -- | -- | -2.1% | -- |
| Rank (Equity Sectoral) | 1 | 2 | 3 | -- |
Exit load, stamp duty and tax
Exit load
0.5% for redemption within 30 Days
Stamp duty on investment: 0.005% (from July 1st, 2020)
from July 1st 2020
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Check past data
Fund management
DTDhananjay TikarihaNov 2023 - PresentView details
DT
Dhananjay Tikariha
Nov 2023 - Present
View details
ABAbhishek BisenNov 2023 - PresentView details
AB
Abhishek Bisen
Nov 2023 - Present
View details
About Kotak Healthcare Fund Direct Growth
Kotak Healthcare Fund Direct Growth is a Equity Mutual Fund Scheme launched by Kotak Mahindra Mutual Fund. This scheme was made available to investors on 05 Aug 1994. Dhananjay Tikariha is the Current Fund Manager of Kotak Healthcare Fund Direct Growth fund. The fund currently has an Asset Under Management(AUM) of ₹5,91,225 Cr and the Latest NAV as of 09 Jun 2026 is ₹15.87.
The Kotak Healthcare Fund Direct Growth is rated Very High risk. Minimum SIP Investment is set to ₹100. Minimum Lumpsum Investment is ₹100. 0.5% for redemption within 30 Days
;
Investment Objective
The scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors.
Fund benchmarkNIFTY Healthcare Total Return Index.
Fund house
Rank (total assets)#5 in India
Total AUM₹5,91,224.54 Cr
Date of Incorporation05 Aug 1994
Launch Date05 Aug 1994
AddressThe Capital Building, Behind ICICI Bank, G Block BKC, Bandra Kurla ComplexBandra (E) Mumbai 400051
Websitewww.camsonline.com
Address7th Floor, Tower II, Rayala Towers, 158, Anna Salai,